Voya Investment Management LLC Opti Nose, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.17 - $1.94 $10,056 - $16,674	8,595 Added 63.03%	22,232 $32,000
Q3 2023 Nov 14, 2023	BUY	$0.93 - $1.38 $12,682 - $18,819	13,637 New	13,637 $16,000
Q2 2021 Aug 16, 2021	SELL	$2.91 - $3.83 $49,798 - $65,542	-17,113 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.2 - $4.98 $19,971 - $31,080	6,241 Added 57.4%	17,113 $71,000
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $7,682 - $15,966	-2,146 Reduced 16.48%	10,872 $81,000
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $16,628 - $30,259	2,652 Added 25.58%	13,018 $120,000
Q2 2019 Aug 14, 2019	BUY	$6.4 - $10.94 $66,342 - $113,404	10,366 New	10,366 $73,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.